Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced Quest AI Companion, a new AI-powered chat feature that helps individuals analyze, understand and act on ...

By using a mobile app and patient portal called MyQuest, “adult users can prompt the tool to define test names and medical ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...

Coronavirus testing delays at Quest Diagnostics, a leading diagnostic information services company, decreased in August as compared to last month, when patients had to wait up to two weeks for results ...

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...

Quest Diagnostics plans to acquire Canada-based community laboratory provider LifeLabs in a deal worth nearly $1 billion. Under the agreement announced July 3, the Secaucus-headquartered testing ...

With demand for COVID-19 tests rapidly drying up, testmakers like Quest Diagnostics are scrambling to find deeper waters that’ll keep them from running aground. Quest, for one, is banking on its core ...

LOS ANGELES (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for distribution to ...